» Articles » PMID: 33082300

Rep1 Microsatellite Length Influences Non-motor Symptoms in Early Parkinson's Disease

Overview
Specialty Geriatrics
Date 2020 Oct 21
PMID 33082300
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Long alpha-synuclein gene promoter (Rep1) allele-carriers are linked to higher risk for Parkinson's disease (PD) and faster motor progression. Non-motor symptoms including autonomic, neuropsychiatric, and sleep disorders are common in PD. However, the relationship between Rep1 microsatellite lengths and non-motor symptoms in early PD remains to be elucidated. 171 consecutive early PD patients were recruited from tertiary clinics and genotyped for Rep1. Multivariable regression analyses were performed to examine associations between Rep1 alleles and non-motor outcome scores. Longer Rep1 alleles significantly associated with higher total Non-Motor Symptom Scale (NMSS) scores (=.006) and Hospital Anxiety and Depression Scale (HADS) depression subscale scores (=.002), after adjusting for covariates and Bonferroni correction. We demonstrated that Rep1 allele length influences overall non-motor symptom burden and depression in early PD patients. Further functional studies to evaluate the role of Rep1 in non-dopaminergic systems may unravel new therapeutic targets for non-motor symptoms in PD.

Citing Articles

Machine Learning for Early Detection of Cognitive Decline in Parkinson's Disease Using Multimodal Biomarker and Clinical Data.

Mohammadi R, Ng S, Tan J, Ng A, Deng X, Choi X Biomedicines. 2025; 12(12.

PMID: 39767666 PMC: 11674004. DOI: 10.3390/biomedicines12122758.


The Impact of Variations and Its Product Alpha-Synuclein on Non-Motor Features of Parkinson's Disease.

Magistrelli L, Contaldi E, Comi C Life (Basel). 2021; 11(8).

PMID: 34440548 PMC: 8401994. DOI: 10.3390/life11080804.


"Janus-Faced" α-Synuclein: Role in Parkinson's Disease.

Ray B, Mahalakshmi A, Tuladhar S, Bhat A, Srinivasan A, Pellegrino C Front Cell Dev Biol. 2021; 9:673395.

PMID: 34124057 PMC: 8194081. DOI: 10.3389/fcell.2021.673395.

References
1.
Friedman J, Beck J, Chou K, Clark G, Fagundes C, Goetz C . Fatigue in Parkinson's disease: report from a mutidisciplinary symposium. NPJ Parkinsons Dis. 2016; 2. PMC: 4883681. DOI: 10.1038/npjparkd.2015.25. View

2.
Starkstein S, Mayberg H, Preziosi T, Andrezejewski P, Leiguarda R, Robinson R . Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 1992; 4(2):134-9. DOI: 10.1176/jnp.4.2.134. View

3.
. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003; 18(7):738-50. DOI: 10.1002/mds.10473. View

4.
Chiba-Falek O, Nussbaum R . Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet. 2001; 10(26):3101-9. DOI: 10.1093/hmg/10.26.3101. View

5.
Schapira A, Chaudhuri K, Jenner P . Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017; 18(7):435-450. DOI: 10.1038/nrn.2017.62. View